Nonsteroidal Anti-Inflammatory Drug-Induced Hepatic Disorders

[1]  L. G. García Rodríguez,et al.  Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. , 1994, Archives of internal medicine.

[2]  S. Gutthann,et al.  The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. , 1993 .

[3]  B. Strom,et al.  Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. , 1993, Archives of internal medicine.

[4]  K. Ishak,et al.  Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration. , 1993, Gastroenterology.

[5]  A. Walker,et al.  The role of non-steroidal anti-inflammatory drugs in acute liver injury. , 1992, BMJ.

[6]  H. Jick,et al.  Liver Disease Associated With Diclofenac, Naproxen, and Piroxicam , 1992, Pharmacotherapy.

[7]  K. Hepps,et al.  Severe cholestatic jaundice associated with piroxicam. , 1991, Gastroenterology.

[8]  D. Zakim,et al.  Diclofenac-associated hepatotoxicity. , 1990, JAMA.

[9]  H. Zimmerman,et al.  Update of Hepatotoxicity Due to Classes of Drugs in Common Clinical Use: Non-Steroidal Drugs, Anti-Inflammatory Drugs, Antibiotics, Antihypertensives, and Cardiac and Psychotropic Agents , 1990, Seminars in liver disease.

[10]  C. Bénichou Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.

[11]  R. Planas,et al.  Fatal submassive necrosis of the liver associated with piroxicam. , 1990, The American journal of gastroenterology.

[12]  S. Pignata,et al.  Sulindac-induced severe hepatitis. , 1988, American Journal of Gastroenterology.

[13]  M MurieCarrillodeAlbornoz,et al.  [Toxic and drug-induced hepatitis]. , 1988 .

[14]  R. Northington,et al.  Hepatic safety of two analgesics used over the counter: Ibuprofen and aspirin , 1986, Clinical pharmacology and therapeutics.

[15]  D. Samuel,et al.  Emergency liver transplantation for fulminant hepatitis. , 1987, Annals of internal medicine.

[16]  M. Vyberg,et al.  Acute cholangitis and pancreatitis associated with sulindac (clinoril) , 1987, Histopathology.

[17]  H. Jick,et al.  Outpatient Drug‐Induced Parenchymal Liver Disease Requiring Hospitalization , 1986, Journal of clinical pharmacology.

[18]  J. Mcnicholl,et al.  Fatal hepatitis associated with diclofenac. , 1986, Gut.

[19]  R. Williams,et al.  Subacute hepatic necrosis induced by piroxicam. , 1986, British medical journal.

[20]  C. Y. Lee,et al.  Acute intoxication due to ibuprofen overdose. , 1986, Archives of Pathology & Laboratory Medicine.

[21]  H. Zimmerman Hepatic effects of oxaprozin , 1986 .

[22]  D. Schapira,et al.  Diclofenac-induced hepatotoxicity. , 1986, Postgraduate medical journal.

[23]  L. Powell,et al.  Sulindac hepatotoxicity: effects of acute and chronic exposure. , 1985, Australian and New Zealand journal of medicine.

[24]  H. Jick,et al.  A followup study of ibuprofen users. , 1985, The Journal of rheumatology.

[25]  J. Bernuau,et al.  Hépatite fulminante chez une femme prenant de la glafénine et du diclofénac. , 1985 .

[26]  V. Levy,et al.  [Acute fatal hepatitis during treatment with diclofenac (Voltarène)]. , 1984, Gastroenterologie clinique et biologique.

[27]  C. Seckman,et al.  Safety profile: fifteen years of clinical experience with ibuprofen. , 1984, The American journal of medicine.

[28]  H. Hartmann,et al.  Prolonged cholestatic jaundice and leukopenia associated with piroxicam. , 1984, Zeitschrift fur Gastroenterologie.

[29]  Lewis Jh Hepatic toxicity of nonsteroidal anti-inflammatory drugs. , 1984 .

[30]  R. Spector,et al.  Serious adverse reactions associated with sulindac. , 1982, Archives of internal medicine.

[31]  Y. Giroux,et al.  Cholestatic jaundice caused by sulindac. , 1982, Canadian journal of surgery. Journal canadien de chirurgie.

[32]  E. Brewer,et al.  The toxicity of nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis. , 1982, The Journal of rheumatology.

[33]  E. Fagman,et al.  Hepatitis associated with use of sulindac in a child. , 1981, The Journal of pediatrics.

[34]  K. Ishak,et al.  Phenylbutazone liver injury: A clinical‐pathologic survey of 23 cases and review of the literature , 1981, Hepatology.

[35]  D. Labrecque,et al.  Sulindac (Clinoril) hepatitis. , 1981, Gastroenterology.

[36]  F. Smith,et al.  Life-threatening hypersensitivity to sulindac. , 1980, JAMA.

[37]  M. Moura,et al.  JAUNDICE ASSOCIATED WITH NAPROXEN , 1980, Postgraduate medical journal.

[38]  Van Berge Henegouwen Gp,et al.  Drug-induced liver injury. , 1980 .

[39]  J. Bravo,et al.  Fatty liver and pleural effusion with ibuprofen therapy. , 1977, Annals of internal medicine.

[40]  J. Miller,et al.  Lymphopenia and hepatic toxicity with ibuprofen. , 1977, The Journal of pediatrics.

[41]  I. Law,et al.  Jaundice associated with naproxen. , 1976, New England Journal of Medicine.

[42]  Leon Schiff,et al.  Diseases of the liver , 1975 .

[43]  M. Cuthbert Section 4 Adverse reactions to non-steroidal antirheumatic drugs , 1974 .

[44]  B. H. Bass Letter: Jaundice associated with naproxen. , 1974, Lancet.

[45]  J. L. Grech,et al.  Hepatitis with biliverdinaemia in association with indomethacin therapy. , 1967, British medical journal.

[46]  J. Jacobs Sudden death in arthritic children receiving large doses of indomethacin. , 1967, JAMA.

[47]  M. Scharyj,et al.  Fatal hepatitis probably due to indomethacin. , 1967, JAMA.